Mutations of the Wiskott-Aldrich syndrome gene (WAS) are responsible for Wiskott- Aldrich syndrome (WAS), a disease characterized by thrombocytopenia, eczema, immunodeficiency, and autoimmunity. Mice with conditional deficiency of Was in B lymphocytes (B/WcKO) have revealed a critical role for WAS protein (WASP) expression in B lymphocytes in the maintenance of immune homeostasis. Neural WASP (N-WASP) is a broadly expressed homolog of WASP, and regulates B-cell signaling bymodulating B-cell receptor (BCR) clustering and internalization.Wehave generated a double conditional mouse lacking both WASP and N-WASP selectively in B lymphocytes (B/DcKO). Compared with B/WcKO mice, B/DcKO mice showed defective B-lymphocyte proliferation and impaired antibody responses to T-celldependent antigens, associated with decreased autoantibody production and lack of autoimmune kidney disease. These results demonstrate that N-WASP expression in B lymphocytes is required for the development of autoimmunity of WAS and may represent a novel therapeutic target in WAS.
|Titolo:||N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome|
|Data di pubblicazione:||2015|
|Appare nelle tipologie:||01.01 - Articolo su rivista|
File in questo prodotto:
|2015_N-WASP is required for B-cellÔÇômediated autoimmunity in Wiskott-Aldrich syndrome.pdf||Documento in versione editoriale||Administrator Richiedi una copia|